発表論文

自然科学等における学術雑誌の影響度の指標として,一般にImpact Factor (IF) が用いられています。

当研究室では

  • IFの高い雑誌に論文を投稿すること
  • 広く引用される論文を投稿すること

を目標に,日々研究に打ち込んでいます。ここでは2005年以降の当研究室の業績を公開します。

(Times Citedの数字は,2019年7月時点における引用数です)


2021年度

  1. Harada, N.; Okuyama, M.; Teraoka, Y.; Arahori, Y.; Shinmori, Y.; Horiuchi, H.; Luis, P.; Joseph, A.; Kitakaze, T.; Matsumuta, S.; Hira, T.; Yamamoto, N.; Inui, T.; Goshima, N.; Schneider, C.; Inui, H.; Yamaji, R.
    Identification of G protein-coupled receptor 55 (GPR55) as a target of curcumin. NPJ Sci. Food. 6, 4 (2022).
    (Times Cited: 0)
  2. Sakajiri, T.; Nakatsuji, M.; Teraoka, Y.; Furuta, K.; Ikuta, K.; Shibusa, K.; Sugano, E.; Tomita, H.; Inui, T.; Yamamura, T.
    Zinc mediates the interaction between ceruloplasmin and apo-transferrin for the efficient transfer of Fe(III) ions.  Metallomics. (2021).
    (Times Cited: 0)
  3. Nakatsuji, M.; Sugiura, K.; Suda, K.; Sakurai, M.; Ubatani, M.; Muroya, H.; Okubo, R.; Noguchi, R.; Kamata, Y.; Fukutomi, Y.; Ishibashi, O.; Nishimura, S.; Inui, T.
    Structure-based prediction of the IgE epitopes of the major dog allergen Can f 1. FEBS. J. 288, 6079-6304(2021).
    (Times Cited: 0)
  4. Okada,T; Inui,T
  5. Tsujimoto,A.; Uehara,H.; Yoshida, H.; Nishio, M.; Furuta, K.Inui, T.; Matsumoto, A; Morita, S.; Tanaka, M.; Kojima, C.
    Different Hydration States and Passive Tumor Targeting Ability of Polyethylene Glycol-Modified Dendrimers with High and Low PEG Density. Mater. Sci. Eng. C 126, 112159 (2021).
    (Times Cited: 0)

総説

  1. Nakatsuji, M.; Inui, T.
    生体内輸送タンパク質による難水溶性薬剤の可溶化と経口投与. Bio Industry. 38, 10-17(2021).
  2. Nakatsuji, M.Inui, T.医薬品のDDSにおけるL-PGDS技術概要および開発事例. 情報機構, 149-160 (2021).

2019年度

  1. Imamura, A.; Okada, T.; Mase, H.; Otani, T.; Kobayashi, T.; Tamura, M.; Kubata, K.; Inoue, K.; Robert P. Rambo.; Uchiyama, S.; Ishii, K.; Nishimura, S.Inui, T.
    Allosteric regulation accompanied by oligomeric state changes of Trypanosoma brucei GMP reductase through cystathionine-β-synthase domain. Nat. Commun. 11, 1837 (2020).
    (Times Cited: 0)

2018年度

  1. Islam, Z.; Inui, T.; Ishibashi, O.
    Gpr 137b is an orphan-G-protein-coupled receptor that regulates M2 Macrophages polarization. Biochem. Biophys. Res. Commun.  509, 657-663 (2019)
    (Times Cited: 1)
  2. Yamamoto, K.; Ishibashi, O.; Sugiura, K.; Ubatani, M.; Sakaguchi, M.; Nakatsuji, M.; Shimamoto, S.; Noda, M.; Uchiyama, S.; Fukutomi, Y.; Nishimura, S.; Inui, T.
    Crystal structure of the dog allergen Can f 6 and structure-based implications of its cross-reactivity with the cat allergen Fel d 4. Sci. Rep. 9, 1503 (2019)
    (Times Cited: 5)
  3. Horikawa, A.; Yoneda, T.; Yaoita, E.; Yamaguchi, K.; Shigenobu, S.; Kuramochi, M.; Yamate, J.; Inui, T.; Ishibashi, O.
    A novel splicing variant of small nucleolar RNA host gene 4 is a podocyte-selective noncoding RNA upregulated in response to puromycin aminonucleoside-induced podocyte injury. J. Biochem. 10, 1093 (2018)
    (Times Cited: 1)
  4. Jikuzono, T.; Horikawa, A.; Ishikawa, T.; Hirokawa, M.; Sugitani, I.; Inui ,T.; Ishibashi, O.
    Proteinase K treatment improves RNA recovery from thyroid cells fixed with liquid-based cytology solution. BMC Res Notes. 11, 822 (2018)
    (Times Cited: 1)
  5. Isibashi, O.; Akagi, I.; Ogawa, Y.; Inui, T.
    MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway. Biochem. Biophys. Res. Commun. 501, 507-513 (2018)
    (Times Cited: 12)

2017年度

  1. Doi, H.; Kida, T.; Nishino, K.; Nakatsuji, M.; Sakamoto, S.; Shimizu, S.; Teraoka, Y.; Tamura, Y.; Kataoka, Y.; Inui, T.
    Solubility-Improved 10-O-Substituted SN-38 Derivatives with Antitumor Activity. ChemMedChem. 12, 1715–1722 (2017).
    (Times Cited: 4)
  2. Teraoka, Y.; Kume, S.; Lin, Y.; Atsuji, S.; Inui, T.
    Comprehensive Evaluation of the Binding of Lipocalin-Type Prostaglandin D Synthase to Poorly Water-Soluble Drugs. Mol. Pharm. 14, 3558–3567 (2017).
    (Times Cited: 5)
  3. Sato, N.; Wakabayashi, M.; Nakatsuji, M.; Kashiwagura, H.; Shimoji, N.; Sakamoto, S.; Ishida, A.; Lee, J.; Lim, B.; Ueno, N. T.; Ishihara, H.; Inui, T.
    MEK and PI3K catalytic activity as predictor of the response to molecularly targeted agents in triple-negative breast cancer. Biochem. Biophys. Res. Commun. 489, 484–489 (2017).
    (Times Cited: 10)
  4. Kinoshita, M.; Lin, Y.; Nakatsuji, M.; Inui, T.; Lee, Y. H.
    Kinetics and polymorphs of yeast prion Sup35NM amyloidogenesis. Int. J. Biol. Macromol. 102, 1241–1249 (2017).
    (Times Cited: 3)

 2016年度

  1. Ishibashi, O.; Sakuragi, K.; Fukutomi, Y.; Kawakami, Y.; Kamata, Y.; Sakurai, M.; Nakayama, S.; Uchiyama, H.; Kobayashi, H.; Kojima, H.; Inui, T.
    Lip b 1 is a novel allergenic protein isolated from the booklouse, Liposcelis bostrychophila. Allergy 72, 918–926 (2017).
    (Times Cited: 9)
  2. Shinya, S.; Nishimura, S.; Kitaoku, Y.; Numata, T.; Kimoto, H.; Kusaoke, H.; Ohnuma, T.; Fukamizo, T.
    Mechanism of chitosan recognition by CBM32 carbohydrate-binding modules from a Paenibacillus sp. IK-5 chitosanase/glucanase. Biochem. J. 473, 1085–1095 (2016).
    (Times Cited: 19)
  3. Mizoguchi, M.; Nakatsuji, M.; Takano, J.; Ishibashi, O.; Wada, K.; Inui, T.
    Development of pH-independent drug release formulation using lipocalin-type prostaglandin D synthase. J. Pharm. Sci. S0022-3549(15)00176-8 (2016).
    (Times Cited: 2)

2015年度

  1. Kubo, T.; Nakajima, H.; Nakatsuji, M.; Itakura, M.; Kaneshige, A.; Azuma, Y. T.; Inui, T.; Takeuchi, T.
    Active site cysteine-null glyceraldehyde-3-phosphate dehydrogenase (GAPDH) rescues nitric oxide-induced cell death. Nitric Oxide 53, 13–21 (2016).
    (Times Cited: 12)
  2. Bessho, T.; Okada, T.; Kimura, C.; Shinohara, T.; Tomiyama, A.; Imamura, A.; Kuwamura, M.; Nishimura, K.; Fujimori, K.; Shuto, S.; Ishibashi, O.; Kubata, K.; Inui, T.
    Novel Characteristics of Trypanosoma brucei Guanosine 5′-monophosphate Reductase Distinct from Host Animals. PLOS Negl. Trop. Dis. 10, e0004339 (2016).
    (Times Cited: 4)
  3. Itakura, M.; Nakajima, H.; Kubo, T.; Semi, Y.; Kume, S.; Higashida, S.; Kaneshige, A.; Kuwamura, M.; Harada, N.; Kita, A.; Azuma, Y. T.; Yamaji, R.; Inui, T.; Takeuchi, T.
    Glyceraldehyde-3-phosphate Dehydrogenase Aggregates Accelerate Amyloid-β Amyloidogenesis in Alzheimer Disease. J. Biol. Chem. 290, 26072–26087 (2015).
    (Times Cited: 38)
  4. Nakatsuji, M.; Inoue, H.; Kohno, M.; Saito, M.; Tsuge, S.; Shimizu, S.; Ishida, A.; Ishibashi, O.; Inui, T.
    Human Lipocalin-type Prostaglandin D Synthase-Based Drug Delivery System for Poorly Water-Soluble Anti-Cancer Drug SN-38. PLOS ONE 10, e0142206 (2015).
    (Times Cited: 4)
  5. Nakajima, H.; Kubo, T.; Ihara, H.; Hikida, T.; Danjo, T.; Nakatsuji, M.; Shahani, N.; Itakura, M.; Ono, Y.; Azuma, Y.; Inui, T.; Kamiya, A.; Sawa, A.; Takeuchi, T.
    Nuclear-translocated Glyceraldehyde-3-phosphate Dehydrogenase Promotes Poly(ADP-ribose) Polymerase-1 Activation during Oxidative/Nitrosative Stress in Stroke. J. Biol. Chem. 290, 14493–14503 (2015).
    (Times Cited: 31)
  6. Mizoguchi, M.; Nakatsuji, M.; Inoue, H.; Yamaguchi, K.; Sakamoto, A.; Wada, K.; Inui, T.
    Novel oral formulation approach for poorly water-soluble drug using lipocalin-type prostaglandin D synthase. Eur. J. Pharm. Sci. 74, 77–85 (2015).
    (Times Cited: 9)

2014年度

  1. Yoneyama, K.; Ishibashi, O.; Kawase, R.; Kurose, K.; Takeshita, T.
    miR-200a, miR-200b and miR-429 Are Onco-miRs that Target the PTEN Gene in Endometrioid Endometrial Carcinoma. Anticancer Res. 35, 1401–1410 (2015).
    (Times Cited: 58)
  2. Akagi, I.; Ishibashi, O.; Matsutani, T.; Hagiwara, N.; Matsuda, A.; Nomura, T.; Makino, H.; Yoshida, H.; Miyashita, M.; Uchida, E.
    Comprehensive Analysis of MicroRNA and mRNA Expression in Normal and Tumorous Human Esophageal Squamous Cell Lines Using Microarray Datasets. Dataset Papers Sci. 376541 (2014).
    (Times Cited: 1)
  3. Ishibashi, O.; Inui, T.
    Identification of endoglin-dependent BMP-2-induced genes in the murine periodontal ligament cell line PDL-L2. J. Mol. Signal. 9, 5 (2014).
    (Times Cited: 3)
  4. Ishibashi, O.; Inui, T.
    Dataset of microarray analysis to identify endoglin-dependent bone morphogenetic protein-2-responsive genes in the murine periodontal ligament cell line PDL-L2. Genomics Data 2, 24–26 (2014).
    (Times Cited: 2)
  5. Inui, T.; Mase, M.; Shirota, R.; Nagashima, M.; Okada, T.; Urade, Y.
    Lipocalin-type prostaglandin D synthase scavenges biliverdin in the cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 34, 1558–1567 (2014).
    (Times Cited: 19)

2013年度

  1. Takahashi, T.; Zenno, S.; Ishibashi, O.; Takizawa, T.; Saigo, K.; Ui-Tei, K.
    Interactions between the non-seed region of siRNA and RNA-binding RLC/RISC proteins, Ago and TRBP, in mammalian cells. Nucleic Acids Res. 42, 5256–5269 (2014).
    (Times Cited: 37)
  2. Kume, S.; Lee, Y. H.; Nakatsuji, M.; Teraoka, Y.; Yamaguchi, K.; Goto, Y.; Inui, T.
    Fine-tuned broad binding capability of human lipocalin-type prostaglandin D synthase for various small lipophilic ligands. FEBS Lett. 588, 962–969 (2014).
    (Times Cited: 13)
  3. Kamata, A.; Saito, M.; Irikura, D.; Yahata, Y.; Ohnishi, T.; Bessho, T.; Inui, T.; Watanabe, M.; Sugita-Konishi, Y.
    A toxin isolated from Sarcocystis fayeri in raw horsemeat may be responsible for food poisoning. J. Food Prot. 77, 814–819 (2014).
    (Times Cited: 24)
  4. Ishibashi, O.
    Bone Morphogenetic Protein-2 Desensitizes MC3T3-E1 Osteoblastic Cells to Estrogen Through Transcriptional Downregulation of Estrogen Receptor 1. J. Bone Metab. 20, 83–88 (2013).
    (Times Cited: 4)

2012年度

  1. Ohkuchi, A.; Ishibashi, O.; Hirashima, C.; Takahashi, K.; Matsubara, S.; Takizawa, T.; Suzuki, M.
    Plasma level of hydroxysteroid (17-β) dehydrogenase 1 in the second trimester is an independent risk factor for predicting preeclampsia after adjusting for the effects of mean blood pressure, bilateral notching and plasma level of soluble fms-like tyrosine kinase 1/placental growth factor ratio. Hypertens. Res. 35, 1151–1158 (2012).
    (Times Cited: 19)
  2. Mase, Y.; Ishibashi, O.; Ishikawa, T.; Takizawa, T.; Kiguchi, T.; Ohba, T.; Katabuchi, H.; Takeshita, T.; Takizawa, T.
    MiR-21 is enriched in the RNA-induced silencing complex and targets COL4A1 in human granulosa cell lines. Reprod. Sci. 19, 1030–1040 (2012).
    (Times Cited: 22)
  3. Bessho, T.; Morii, S.; Kusumoto, T.; Shinohara, T.; Noda, M.; Uchiyama, S.; Shuto, S.; Nishimura, S.; Djikeng, A.; Duszenko, M.; Martin, S.; Inui, T.; Kubata, K.
    Characterization of the novel Trypanosoma brucei inosine 5′-monophosphate dehydrogenase. Parasitology 140, 735–745 (2012).
    (Times Cited: 10)
  4. Kojima, C.; Suehiro, T.; Watanabe, K.; Ogawa, M.; Fukuhara, A.; Nishisaka, E.; Harada, A.; Kono, K.; Inui, T.; Magata, Y.
    Doxorubicin-Conjugated Dendrimer/Collagen Hybrid Gels for Metastasis-Associated Drug Delivery System. Acta Biomater. 9, 5673–5680 (2013).
    (Times Cited: 63)
  5. Kume, S.; Lee, Y. H.; Miyamoto, Y.; Fukada, H.; Goto, Y.; Inui, T.
    Systematic Interaction Analysis of Human Lipocalin-type Prostaglandin D Synthase with Small Lipophilic Ligands. Biochem. J. 446, 279–289 (2012).
    (Times Cited: 22)
  6. Kojima, C.; Fukada, H.; Inui, T.
    Synthesis and binding properties of peptidomimetics based on a dendritic polymer. Polymer J. 45, 339–345 (2012).
    (Times Cited: 4)
  7. Fukuhara, A.; Nakajima, H.; Miyamoto, Y.; Inoue, K.; Kume, S.; Lee, Y. H.; Noda, M.; Uchiyama, S.; Shimamoto, S.; Nishimura, S.; Ohkubo, T.; Goto, Y.; Takeuchi, T.; Inui, T.
    Drug delivery system for poorly water-soluble compounds using lipocalin-type prostaglandin D synthase. J. Control. Release 159, 143–150 (2012).
    (Times Cited: 21)
  8. Fukuhara, A.; Yamada, M.; Fujimori, K.; Miyamoto, Y.; Kusumoto, T.; Nakajima, H; Inui, T.
    Lipocalin-type Prostaglandin D Synthase Protects Against Oxidative Stress-induced Neuronal Cell Death. Biochem. J. 443, 75–84 (2012).
    (Times Cited: 46)

2011年度

  1. Miyamoto, Y.; Noda, Y.; Iida, T.; Yamaguchi, K.; Nishimura, S.; Tanaka, A.; Segawa, S.; Inui, T.
    NMR and CD analysis of an intermediate state in the thermal unfolding process of mouse lipocalin-type prostaglandin D synthase. J. Biochem. 151, 335–342 (2012).
    (Times Cited: 0)
  2. Fujimori, K.; Fukuhara, A.; Inui, T.; Allhorn, M.
    Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase. J. Neurochem. 120, 279–291 (2012).
    (Times Cited: 24)
  3. Lee, Y. H.; Kume, S.; Inui, T.; Goto, Y.
    A Calorimetric Approach with Structure-Based Thermodynamics for Molecular Interactions. Netsu Sokutei 38, 165–173 (2011).
    (Times Cited: 2)

2010年度

  1. Tsuji, H.; Nishimura, S.; Inui, T.; Kado, Y.; Ishikawa, K.; Nakamura, T.; Uegaki, K.
    Kinetic and crystallographic analyses of the catalytic domain of chitinase from Pyrococcus furiosus – the role of conserved residues in the active site. FEBS. J. 277, 2683–2695 (2010).
    (Times Cited: 38)
  2. Miyamoto, Y.; Nishimura, S.; Inoue, K.; Shimamoto, S.; Yoshida, T.; Fukuhara, A.; Yamada, M.; Urade, Y.; Yagi, N.; Ohkubo, T.; Inui, T.
    Structural analysis of lipocalin-type prostaglandin D synthase complexed with biliverdin by small-angle X-ray scattering and multi-dimensional NMR. J. Struct. Biol. 169, 209–218 (2010).
    (Times Cited: 37)

2009年度

  1. Nakajima, H.; Amano, W.; Fukuhara, A.; Kubo, T.; Misaki, S.; Azuma, Y.; Inui, T.; Takeuchi, T.
    An aggregate-prone mutant of human glyceraldehyde-3-phosphate dehydrogenase augments oxidative stress-induced cell death in SH-SY5Y cells. Biochem. Biophys. Res. Commun. 390, 1066–1071 (2009).
    (Times Cited: 27)
  2. Nakajima, H.; Amano, W.; Kubo, T.; Fukuhara, A.; Ihara, H.; Azuma, Y.; Tajima, H.; Inui, T.; Sawa, A.; Takeuchi, T.
    Glyceraldehyde-3-phosphate Dehydrogenase Aggregate Formation Participates in Oxidative Stress-induced Cell Death. J. Biol. Chem. 289, 34331–34341 (2009).
    (Times Cited: 110)
  3. Sugimoto, H.; Nakaura, M.; Nishimura, S.; Karita, S.; Miyake, H.; Tanaka, A.
    Kinetically trapped metastable intermediate of a disulfide-deficient mutant of the starch-binding domain of glucoamylase. Protein. Sci. 18, 1715–1723 (2009).
    (Times Cited: 8)
  4. Inoue, K.; Yagi, N.; Urade, Y.; Inui, T.
    Compact Packing of Lipocalin-type Prostaglandin D Synthase Induced by Binding of Lipophilic Ligands. J. Biochem. 145, 169–175 (2009).
    (Times Cited: 26)
  5. Okamoto, Y.; Nagai, Y.; Fujitake, N.; Popiel, H. A.; Yoshioka, T.; Toda, T.; Inui, T.
    Surface plasmon resonance characterization of specific binding of polyglutamine aggregation inhibitors to the expanded polyglutamine stretch. Biochem. Biophys. Res. Commun. 378, 634–639 (2009).
    (Times Cited: 12)

2008年度

  1. Li, W.; Mase, M.; Inui, T.; Shimoda, M.; Isomura, K.; Oda, H.; Yamada, K.; Urade, Y.
    Pharmacokinetics of recombinant human lipocalin-type prostaglandin D synthase/β-trace in canine. Neurosci. Res. 61, 289–293 (2008).
    (Times Cited: 17)
  2. Tomita, A.; Kasaoka, T.; Inui, T.; Toyoshima, M.; Nishiyama, N.; Saiki, H.; Iguchi, H.; Nakajima, M.
    Human breast adenocarcinoma (MDA-231) and human lung squamous cell carcinoma (Hara) do not have the ability to cause bone resorption by themselves during the establishment of bone metastasis. Clin. Exp. Metastasis. 25, 437–444 (2008).
    (Times Cited: 15)
  3. Iida T.; Nishimura, S.; Mochizuki, M.; Uchiyama, S.; Ohkubo, T.; Urade, Y.; Tanaka, A.; Inui, T.
    Thermal unfolding mechanism of lipocalin-type prostaglandin D synthase. FEBS J. 275, 233–241 (2008).
    (Times Cited: 13)
  4. Cui, Y.; Kataoka, Y.; Inui, T.; Mochizuki, T.; Onoe, H.; Matsumura K.; Urade, Y.; Yamada, H.; Watanabe, Y.
    Up-regulated neuronal COX-2 expression after cortical spreading depression is involved in non-REM sleep induction in rats. J. Neurosci. Res. 86, 929–936 (2008).
    (Times Cited: 23)

2007年度

  1. Inui, T.
    Folding and unfolding mechanism of lipocalin-type prostaglandin D synthase. Prostaglandin D2 Synthase – A Multitude of Biological Functions, Research Signpost. 15–28 (2007).
    (Times Cited: 0)
  2. Shimamoto, S.; Yoshida, T.; Inui, T.; Gohda, K.; Kobayashi, Y.; Fujimori, K.; Aritake, K.; Urade, Y.; Ohkubo, T.
    NMR Solution Structure of Lipocalin-type Prostaglandin D Synthase: evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavity. J. Biol. Chem. 282, 31373–31379 (2007).
    (Times Cited: 61)
  3. Nakajima, H.; Amano, W.; Fujita, A.; Fukuhara, A.; Azuma, Y.; Hata, F.; Inui, T.; Takeuchi, T.
    The Active Site Cysteine of the Proapoptotic Protein Glyceraldehyde-3-phosphate Dehydrogenase Is Essential in Oxidative Stress-induced Aggregation and Cell Death. J. Biol. Chem. 282, 26562–26574 (2007).
    (Times Cited: 158)
  4. Nagai, Y.; Inui, T.; Popiel, H. A.; Fujikake, N.; Hasegawa, K.; Urade, Y.; Goto, Y.; Naiki, H.; Toda, T.
    A toxic monomeric conformer of the polyglutamine protein. Nat. Struct. Mol. Biol. 14, 332–340 (2007).
    (Times Cited: 326)
  5. Irikura, D.; Inui, T.; Beuckmann, C. T.; Aritake, K.; Schreiber, G.; Miyano, M.; Inoue, T.; Urade, Y.
    Characterization of a Major Secretory Protein in the Cane Toad (Bufo marinus) Choroid Plexus as an Amphibian Lipocalin-type Prostaglandin D Synthase. J. Biochem. 141, 173–180 (2007).
    (Times Cited: 8)

2006年度

  1. Ishibashi, O.; Niwa, S.; Kadoyama, K.; Inui, T.
    MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration. Life Sci. 79, 1657–1660 (2006).
    (Times Cited: 85)
  2. Mohri, I.; Taniike, M.; Taniguchi, H.; Kanekiyo, T.; Aritake, K.; Inui, T.; Fukumoto, N.; Eguchi, N.; Kushi, A.; Sasai, H.; Kanaoka, K.; Ozono, K.; Narumiya, S.; Suzuki, K.; Urade, Y.
    Prostaglandin D2-Mediated Microglia/Astrocyte Interaction Enhances Astrogliosis and Demyelination in twitcher. J. Neurosci. 26, 4383–4393 (2006).
    (Times Cited: 141)
  3. Fujimori, K.; Inui, T.; Uodome, N.; Kadoyama, K.; Aritake, K.; Urade, Y.
    Zebrafish and chicken lipocalin-type prostaglandin D synthase homologues: Conservation of mammalian gene structure and binding ability for lipophilic molecules, and difference in expression profile and enzyme activity. Gene 375, 14–25 (2006).
    (Times Cited: 37)
  4. Ogawa, K.; Nishimura, S.; Doi, M.; Takashima, H.; Nishi, Y.; Yoshida, T.; Ohkubo, T.; Kobayashi, Y.
    Conformational analysis of human calcitonin in solution. J. Pept. Sci. 12, 51–57 (2006).
    (Times Cited: 4)

2005年度

  1. Iida, T.; Kamo, M.; Uozumi, N.; Inui, T.; Imai, K.
    Further application of a two-step heparin affinity chromatography method using divalent cations as eluents: Purification and identification of membrane-bound heparin binding proteins from the mitochondrial fraction of HL-60 cells. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 823, 209–212 (2005).
    (Times Cited: 3)
  2. Kubata, B. K.; Inoue, T.; Okano, Y.; Kabututu, Z.; Martin, S. K.; Lazarus, M.; Duszenko, M.; Sumii, Y.; Kusakari, Y.; Matsumura, H.; Kai, Y.; Sugiyama, S.; Inaka, K.; Inui, T.; Urade, Y.
    Structural and Mutational Analysis of Trypanosoma brucei Prostaglandin H2 Reductase Provides Insight into the Catalytic Mechanism of Aldo-ketoreductases. J. Biol. Chem. 280, 26371–26382 (2005).
    (Times Cited: 27)